BioWorld Asia

Dec. 13, 2006

View Archived Issues

Blindness Gene Identified In Chickens Could Have Impact

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Belgium's ThromboGenics In Novel Biotech Deal With India

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Actelion Shares On Rise As Actelion-1 Now In Phase III

Peptech Ponders Various Ways Of Spending £71.3M

Genfit To List Shares On Alternext Market In Paris

PanGenetics In Deals With Schering-Plough, LayLine

Other News To Note

Newron Raises CHF118.12M In Swiss Initial Public Offering

Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International) Read More

Pharminox, Schering-Plough Enter Deal Worth Up To $40M

Today's news in brief

BioWorld

BioWorld briefs for June 22, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

Illustration of glucose in the blood stream

CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

BioWorld Science

Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...

Saniona reports preclinical data for SAN-2668

BioWorld Science

Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...

Insilico Medicine synthesizes new Nav1.8 blockers

BioWorld Science

Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.